X

Xencor
D

XNCR

7.57000
USD
-0.12
(-1.56%)
مغلق
حجم التداول
38,440
الربح لكل سهم
-2
العائد الربحي
-
P/E
-2
حجم السوق
538,762,608
أصول ذات صلة
ALNY
ALNY
0.47
(0.16%)
289.82 USD
A
AMRN
0.220
(2.00%)
11.220 USD
A
ANIP
0.557
(0.97%)
57.800 USD
GOOG
GOOG
-3.570
(-2.06%)
169.590 USD
REGN
REGN
-8.04
(-1.35%)
588.61 USD
S
SGMO
-0.02030
(-4.11%)
0.47370 USD
المزيد
الأخبار المقالات

العنوان: Xencor

القطاع: Healthcare
الصناعة: Biotechnology
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.